Zhejiang Jutai Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHEJIANG JUTAI PHARM, and what generic and branded alternatives to ZHEJIANG JUTAI PHARM drugs are available?
ZHEJIANG JUTAI PHARM has one approved drug.
Drugs and US Patents for Zhejiang Jutai Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zhejiang Jutai Pharm | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211200-001 | Sep 5, 2019 | AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Zhejiang Jutai Pharm | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211200-002 | Apr 29, 2020 | AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.